Valeant (VRX), DepoMed (DEPO) Sue Watson (WPI) Over Generic Glumetza
Tweet Send to a FriendGet Alerts VRX Hot Sheet
Up)
Trade VRX Now!
Bloomberg reporting Valent Pharma (NYSE: VRX) and DepoMed (Nasdaq: DEPO) have sued Watson (NYSE: WPI), challenging the company's generic glumetza product.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- Bank Leumi le-Israel Moves to Terminate Credit Lines for Elbit Imaging (EMITF)
- Philip Morris (PM) Will Acquire Balance of Mexico Unit in $700M Deal
- XenoPort (XNPT) Arbaclofen Placarbil Phase 3 Misses Endpoints
Create E-mail Alert Related Categories
Corporate News, Litigation
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
